These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19901961)

  • 1. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
    Beck AH; Lee CH; Witten DM; Gleason BC; Edris B; Espinosa I; Zhu S; Li R; Montgomery KD; Marinelli RJ; Tibshirani R; Hastie T; Jablons DM; Rubin BP; Fletcher CD; West RB; van de Rijn M
    Oncogene; 2010 Feb; 29(6):845-54. PubMed ID: 19901961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.
    Demicco EG; Boland GM; Brewer Savannah KJ; Lusby K; Young ED; Ingram D; Watson KL; Bailey M; Guo X; Hornick JL; van de Rijn M; Wang WL; Torres KE; Lev D; Lazar AJ
    Histopathology; 2015 Apr; 66(5):627-38. PubMed ID: 24889065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
    Carneiro A; Francis P; Bendahl PO; Fernebro J; Akerman M; Fletcher C; Rydholm A; Borg A; Nilbert M
    Lab Invest; 2009 Jun; 89(6):668-75. PubMed ID: 19290004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
    Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
    Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
    Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
    PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
    Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
    J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.
    Anderson ND; Babichev Y; Fuligni F; Comitani F; Layeghifard M; Venier RE; Dentro SC; Maheshwari A; Guram S; Wunker C; Thompson JD; Yuki KE; Hou H; Zatzman M; Light N; Bernardini MQ; Wunder JS; Andrulis IL; Ferguson P; Razak ARA; Swallow CJ; Dowling JJ; Al-Awar RS; Marcellus R; Rouzbahman M; Gerstung M; Durocher D; Alexandrov LB; Dickson BC; Gladdy RA; Shlien A
    Nat Commun; 2021 Jul; 12(1):4496. PubMed ID: 34301934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
    Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
    Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.
    Silveira SM; Villacis RA; Marchi FA; Barros Filho Mde C; Drigo SA; Neto CS; Lopes A; da Cunha IW; Rogatto SR
    PLoS One; 2013; 8(6):e67643. PubMed ID: 23825676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated study of aberrant gene copy number and gene expression in GIST and LMS.
    Yang D; Ylipaa A; Yang J; Hunt K; Pollock R; Trent J; Yli-Harja O; Shmulevich I; Nykter M; Zhang W
    Technol Cancer Res Treat; 2010 Apr; 9(2):171-8. PubMed ID: 20218739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
    Espinosa I; Beck AH; Lee CH; Zhu S; Montgomery KD; Marinelli RJ; Ganjoo KN; Nielsen TO; Gilks CB; West RB; van de Rijn M
    Am J Pathol; 2009 Jun; 174(6):2347-56. PubMed ID: 19443701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization.
    Larramendy ML; Kaur S; Svarvar C; Böhling T; Knuutila S
    Cancer Genet Cytogenet; 2006 Sep; 169(2):94-101. PubMed ID: 16938566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes.
    Hemming ML; Fan C; Raut CP; Demetri GD; Armstrong SA; Sicinska E; George S
    Mol Cancer Res; 2020 Sep; 18(9):1302-1314. PubMed ID: 32518213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
    Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
    J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
    Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
    Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.
    Davidson B; Abeler VM; Hellesylt E; Holth A; Shih IeM; Skeie-Jensen T; Chen L; Yang Y; Wang TL
    Gynecol Oncol; 2013 Feb; 128(2):349-55. PubMed ID: 23178314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
    Italiano A; Lagarde P; Brulard C; Terrier P; Laë M; Marques B; Ranchere-Vince D; Michels JJ; Trassard M; Cioffi A; Piperno-Neumann S; Chevreau C; Blay JY; Delcambre C; Isambert N; Penel N; Bay JO; Bonvalot S; Le Cesne A; Coindre JM; Chibon F
    Clin Cancer Res; 2013 Mar; 19(5):1190-6. PubMed ID: 23329812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
    Tian W; Wang G; Yang J; Pan Y; Ma Y
    Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.